Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TRACON Pharmaceuticals, Inc. (DE:T051)
BERLIN:T051
RESEARCH TOOLSreports
TRACON Pharmaceuticals (T051) Ownership - Who Owns TRACON Pharmaceuticals?
1 Followers
TRACON Pharmaceuticals (T051) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
6.29% Other Institutional Investors
93.71% Public Companies and
Individual Investors
The ownership structure of TRACON Pharmaceuticals (DE:T051) stock is a mix of institutional, retail and individual investors. Approximately 6.29% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 93.71% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 14, 2023 | Opaleye Management Inc. >10% Owner | Sold | $1381562 |
| Apr 28, 2023 | Charles Theuer President & Ceo,director | Bought | $35250 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,466,003 | Insider | ― | 1,441,857 | |
| 1,888,474 | Insider | ― | 785,605 | |
| 3,466,003 | Insider | ― | 1,441,857 | |
| 3,466,003 | Insider | ― | 1,441,857 | |
| 3,466,003 | Insider | ― | 1,441,857 | |
| 406,417 | Insider | ― | 169,069 | |
| 3,466,003 | Insider | ― | 1,441,857 | |
| 3,466,003 | Insider | ― | 1,441,857 | |
| 27,754 | Insider | ― | 11,546 | |
| 3,466,003 | Insider | ― | 1,441,857 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,800 | Institution | ― | 6,196 | |
| 4,428 | Institution | ― | 1,988 | |
| 22,638 | Institution | ― | 10,164 | |
| 1,275 | Institution | ― | 572 | |
| 624,398 | Institution | ― | 280,355 | |
| 200,699 | Institution | ― | 90,114 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns TRACON Pharmaceuticals, Inc. (DE:T051)?
According to the latest TipRanks data, approximately 6.29% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 93.71% is held by retail investors.
What percentage of TRACON Pharmaceuticals, Inc. (DE:T051) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.29% of TRACON Pharmaceuticals, Inc. (DE:T051) stock is held by institutional investors.
What percentage of TRACON Pharmaceuticals, Inc. (DE:T051) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.71% of TRACON Pharmaceuticals, Inc. (DE:T051) stock is held by retail investors.
Who owns the most shares of TRACON Pharmaceuticals, Inc. (DE:T051)?
David Mott owns the most shares of TRACON Pharmaceuticals, Inc. (DE:T051).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.